196 related articles for article (PubMed ID: 12087875)
1. Involvement of opioid delta (delta)- and kappa (kappa)-receptors in ischemic preconditioning in a rat model of myocardial infarction.
Valtchanova-Matchouganska A; Ojewole JA
Methods Find Exp Clin Pharmacol; 2002 Apr; 24(3):139-44. PubMed ID: 12087875
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of opioid delta (delta) and kappa ( kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction.
Valtchanova-Matchouganska A; Ojewole JA
Cardiovasc J S Afr; 2003; 14(2):73-80. PubMed ID: 12748744
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antidysrhythmic effects of delta- and kappa-opioid receptor agonists and antagonists on calcium chloride-, adrenaline- and ischemia/reperfusion-induced arrhythmias in rats.
Valtchanova-Matchouganska A; Missankov A; Ojewole JA
Methods Find Exp Clin Pharmacol; 2004; 26(1):31-8. PubMed ID: 14988739
[TBL] [Abstract][Full Text] [Related]
4. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats.
Wang GY; Wu S; Pei JM; Yu XC; Wong TM
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H384-91. PubMed ID: 11123255
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning.
Aitchison KA; Baxter GF; Awan MM; Smith RM; Yellon DM; Opie LH
Basic Res Cardiol; 2000 Feb; 95(1):1-10; discussion 11. PubMed ID: 10752540
[TBL] [Abstract][Full Text] [Related]
7. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G
Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein in acute and delayed preconditioning of the rat heart.
Valtchanova-Matchouganska A; Gondwe M; Nadar A
Cardiovasc J S Afr; 2005; 16(2):118-23. PubMed ID: 15915280
[TBL] [Abstract][Full Text] [Related]
10. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors.
Schultz JE; Hsu AK; Gross GJ
Circulation; 1998 Apr; 97(13):1282-9. PubMed ID: 9570199
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
12. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
[TBL] [Abstract][Full Text] [Related]
13. Role of kappa-opioid receptor activation in pharmacological preconditioning of swine.
Coles JA; Sigg DC; Iaizzo PA
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2091-9. PubMed ID: 12543635
[TBL] [Abstract][Full Text] [Related]
14. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
[TBL] [Abstract][Full Text] [Related]
15. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
Valtchanova-Matchouganska A; Gondwe M; Nadar A
Life Sci; 2004 Jul; 75(8):901-10. PubMed ID: 15193950
[TBL] [Abstract][Full Text] [Related]
16. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
Watson MJ; Holt JD; O'Neill SJ; Wei K; Pendergast W; Gross GJ; Gengo PJ; Chang KJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):423-30. PubMed ID: 16188952
[TBL] [Abstract][Full Text] [Related]
17. Activation of Peripheral Opioid Kappa1 Receptor Prevents Cardiac Reperfusion Injury.
Popov SV; Mukhomedzyanov AV; Tsibulnikov SY; Khaliuli I; Oeltgen PR; Prasad NR; Maslov LN
Physiol Res; 2021 Aug; 70(4):523-531. PubMed ID: 34062075
[TBL] [Abstract][Full Text] [Related]
18. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.
Wong GT; Li R; Jiang LL; Irwin MG
Acta Anaesthesiol Scand; 2010 Apr; 54(4):510-8. PubMed ID: 19878098
[TBL] [Abstract][Full Text] [Related]
19. Diminution of contractile response by kappa-opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein.
Wenzlaff H; Stein B; Teschemacher H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):360-6. PubMed ID: 9774224
[TBL] [Abstract][Full Text] [Related]
20. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction.
Peart JN; Gross ER; Gross GJ
J Cardiovasc Pharmacol; 2004 Mar; 43(3):410-5. PubMed ID: 15076225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
